经尿道前列腺汽化电切术治疗高危前列腺增生症的疗效观察  

The clinical efficacy and safety of transurthral electrovaporization of the prostate （TUVP） for benign prostatic hyperplasia（ BPH） at high risk

作　　者：李旭东[1] 宋贯杰[1] 常艳华[1] 

机构地区：[1]滨州市人民医院泌尿外科,山东省滨州256610

出　　处：《中国基层医药》2011年第12期1602-1603,共2页Chinese Journal of Primary Medicine and Pharmacy

摘　　要：目的 探讨经尿道汽化电切术（TUVP）治疗高危前列腺增生症（BPH）的临床疗效及安全性.方法 回顾性分析采用TUVP治疗的48例高危BPH患者的临床资料,比较术前、术后3个月剩余尿量（PVR）、国际前列腺症状评分（IPSS）、生活质量评分（QOL）等差异.结果 全部患者均安全度过围手术期,术后均获得随访,随访时间3～14个月,48例患者排尿功能恢复良好,无再次排尿困难.患者术前PVR、IPSS、QOL分别为（97.5.±16.9）ml、（28.4±2.3）分、（5.5±0.6）分,术后3个月PVR、IPSS、QOL分别为（30.2±12.3）ml、（8.2±1.3）分、（1.9±0.5）分,手术前后差异均有统计学意义（t=22.31、53.16、31.94,均P〈0.05）.结论 TUVP治疗高危BPH疗效确切,是一种安全的治疗方法.Objective To investigate the clinical efficacy and safety of transurthral electrovaporization of the prostate（TUVP） for benign prostatic hyperplasia（ BPH） at high risk.Methods Forty-eight patients with BPH at high risk were treated with transurthral electrovaporization of the prostate（TUVP）.The clinical data and therapeutic results were measured.Results All patients went through the perioperiative period safely and had been followed up for 3 to 14 months.Postvoid residual （ PVR） , the International Prostate Symptom Score （IPSS） and quality of life （QOL） before operations were （97.5 ± 16.9） ml, （ 28.4 ± 2.3 ） score and （5.5 ±0.6） score respectively.Three months after operation ,PVR ,IPSS and QOL were（ 30.2 ± 12.3 ） ml, （8.2 ± 1.3 ） score and（ 1.9 ±0.5） score respectively,there was significant difference between them（t =22.31,53.16,31.94,all P〈0.05）.Conclusion TUVP is an effective and safe method in treating BPH patients at high risk.

关 键 词：前列腺增生 经尿道前列腺汽化电切除术 

分 类 号：R699[医药卫生—泌尿科学]